Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release


Posted on: 17 Aug 17

~ Takeda announces Aspen Labs as its New Commercial Partner for the Region ~

MEXICO CITY.- Takeda Mexico announced today the signing of an agreement with Aspen Labs as its new commercial partner for Central America & the Caribbean. The agreement covers the distribution of Takeda’s Primary Care portfolio in Gastroenterology and Gynecology from the first quarter of 2018 (Calendar Year), in countries such as Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panama and islands as Dominican Republic, Jamaica, Trinidad & Tobago, Barbados and Curacao.

“By selecting Aspen Labs as our new commercial partner, we are confident in reaching more patients with innovative treatments which will improve the quality of their lives”, said Renata Campos, Area Head LATAM & President of Takeda Brazil.

“I am convinced that this new business relationship will enable Takeda to strengthen our position in different therapeutic areas. We chose Aspen Labs as they share our values and business ethics, and the agreement bolsters our focus on patients”, claimed José Manuel Caamaño, President of Takeda Mexico and Central America and the Caribbean.

“For Aspen Labs this is a great opportunity to represent Takeda’s products in Central America and the Caribbean. We view it as a transformational alliance for the benefit of patients in the region, and both companies,” stated Carlos Abelleyra, CEO of Aspen Labs LATAM.

Takeda has a proud heritage of serving patients in Central America & the Caribbean, having being present there since 1996.

About Takeda:

Takeda Pharmaceutical Company Limited is a pharmaceutical Company driven by research and development (R&D) committed to offer a better health and a brighter future to patients by translating science into medications which transform lives. Takeda focuses its research endeavors globally in the therapeutic areas of oncology, gastroenterology, central nervous system, cardiovascular diseases, and vaccines; in Mexico, it is focused on oncology, gastroenterology, cardio-metabolic diseases, gynecology and OTC. Takeda carries out R&D internally and with its partners in order to stay at the top of innovation. New and novel products, especially in oncology and gastroenterology, and its presence in emerging markets, boost the sustained growth of Takeda. More than 30,000 employees of Takeda all over the world, and more than one thousand in Mexico, have committed to improve the quality of life of patients, by working with our partners in the area of healthcare in more than 70 countries. For further information please visit and

About Aspen Labs:

Aspen is a pharmaceutical laboratory with over 160 years in the market, during which the group has been committed to improve the quality of life and to foster health of people all over the world, by offering further access to effective and high quality medications. It was founded in South Africa and it has more than 10 thousand employees and 26 manufacturing plants throughout the world. Aspen has acquired global trade marks from GSK, MSD and Pfizer, and in Central America it is engaged in different therapeutic areas, such as cardiology, feminine health, critical care and oncology.



For more information:

Editor's Details

Ingrid Perez
+52 55 90004922

Last updated on: 17/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.